Evaluation of uricosuric agents in chronic gout (Q41351103)

29 September 2017

Evaluation of uricosuric agents in chronic gout (English)

1 reference

29 September 2017

OGRYZLO MA

1

1 reference

PMCID

1006984

29 September 2017

HARRISON J

series ordinal

2

1 reference

PMCID

1006984

29 September 2017

language of work or name

English

0 references

publication date

1 December 1957

1 reference

Annals of the Rheumatic Diseases

29 September 2017

1 reference

29 September 2017

16

1 reference

29 September 2017

4

1 reference

29 September 2017

425-437

1 reference

The effect of salicylates and adrenocorticotropic hormone upon the miscible pool of uric acid in gout

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

The effect of phenylbutazone on uric acid metabolism in two normal subjects

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

The uricosuric action of ethyl biscoumacetate

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1006984

Effect of phenylbutazone on uric acid excretion in patients with gout and rheumatoid arthritis

19 August 2018

1 reference

12 December 2020

URIC acid metabolism and gout

1 reference

12 December 2020

Probenecid (benemid); its uses and side-effects in 2,502 patients

1 reference

12 December 2020

The clinical and metabolic effects of benemid in patients with gout

1 reference

12 December 2020

Further observation on the uricosuric effects of probenecid (benemid) in tophaceous gout

1 reference

12 December 2020

1 reference

12 December 2020

Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone

1 reference

12 December 2020

Some observations on 520 gouty patients

1 reference

12 December 2020

Oral phenylbutazone in the treatment of acute gouty arthritis

1 reference

12 December 2020

Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione)

1 reference

12 December 2020

Phenylbutazone (butazolidin) in gout

1 reference

12 December 2020

Radiological evidence of the value of treatment in gout

1 reference

12 December 2020

Therapeutic value of probenecid (benemid) in gout

1 reference

12 December 2020

Gout--now amenable to control

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.16.4.425

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

PMCID

1006984